Europe’s Pharma Paradox

A LinkedIn post said that AZ head honcho, Pascal Soriot warned that Europe risks becoming a “mere sales office” for pharmaceuticals. It sounds so familiar to us in India, that it is tempting to dismiss it as predictable industry pushback.It would be a mistake.Beneath the rhetoric lies discomfort. Europe is not being outcompeted. It is systematically opting out of the innovation economy that it claims to lead. And Germany (the continent’s economic anchor) is about to accelerate that shift.Listen in for details. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com